What Changed
Price Move History
- Daily moves over 5%
- 14 19 sessions, May 4, 2022 to May 12, 2023
- Largest daily move
- +315.4% close of February 17, 2023
- 1-year change
- -81.7% closing prices, May 4, 2022 to May 12, 2023
- 1-month change
- -32.5% closing prices, March 17, 2023 to May 12, 2023
Company Description
Okyo Pharma (OTC: EMMLF) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $22.7M.
EMMLF has declined 81.7% over the past year. The last closing price was $0.8905.
This page collects what Stock Titan holds for EMMLF, including price data and latest news.
Stock Performance
Okyo Pharma (EMMLF) closed at $0.8905 on May 12, 2023. Over the past 12 months, the price has lost 81.7%.
EMMLF Metrics & Rankings
Price returns through May 12, 2023. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Okyo Pharma has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 7 with negative movement. Key topics include offering, IPO, fda approval. View all EMMLF news →
SEC Filings
EMMLF Company Profile & Sector Positioning
Okyo Pharma (EMMLF) operates in the Biotechnology industry within the broader Healthcare sector.
Investors comparing EMMLF often look at related companies in the same sector, including Neuraxis, Inc. (NRXS), FibroBiologics, Inc. (FBLG), CytoMed Therapeutics Limited (GDTC), Stealth Biotherapeutics (MITO), and NanoViricides Inc. (NNVC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate EMMLF's relative position within its industry.